Greenphire and Mytrus Partner to Provide Web-Based Solutions for Patient Recruitment and Retention
Greenphire, based in suburban Philadelphia, and San Francisco startup Mytrus Inc. have developed web-based solutions to streamline the tasks of recruiting, retaining, and efficiently administering clinical trials. Greenphire’s ClinCard System, a web-based patient payment, management, and communication platform, compliments the functionality offered by Mytrus and its methods for allowing patients to participate in clinical research studies from their homes.
Greenphire and Mytrus hope to empower patients to play a larger and more critical role in pharmaceutical development. Mytrus allows patients to use web technology to provide their own study data over the Internet and then be immediately compensated directly to a Greenphire ClinCard debit card the patient carries around in their wallet.
Greenphire’s patent-pending ClinCard technology offers a fully configurable, web-based patient payment, management, and communication engine, enabling sponsor and site administrators to deliver study-specific messaging programs executed by text, email, and voice messages while delivering patient stipends, managing patient travel arrangements, and providing travel reimbursements in a controlled and automated real-time environment. The ClinCard’s functionality is in compliance with industry regulation and implemented according to the requirements of each specific study protocol. The ClinCard System has been proven to drive increased site and patient satisfaction, reduced site and sponsor administration, increased patient retention, increased protocol compliance, and reduced regulatory risk for the sponsor.
Mytrus’model uses web-based tools for recruiting and managing patients from a single remote site in San Francisco. Mytrus studies feature Greenphire’s ClinCard technology to deliver real-time stipend and reimbursement payments to their study participants. Patients receive a ClinCard immediately upon study enrollment and then receive milestone payments as they progress through a study.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
FDA-Approved Gene Therapy Beqvez Shows Sustained Efficacy, Safety in Long-Term Hemophilia B Trial
April 17th 2025Beqvez (fidanacogene elaparvovec), an FDA-approved one-time gene therapy for hemophilia B, demonstrated sustained factor IX expression, low bleeding rates, and a favorable safety profile over long-term follow-up.
